EMN29 study – opportunity & questions

The EMN29 study with Selinexor is ongoing.

If you are a participating site and wish to know more about this study and treatment, you can:

  • Visit the following website:
  • Contact the trial manager:


In addition, Prof. Katja Weisel РPrincipal Investigator of the study Рwill join the ASH 2023 conference in San Diego, 9-12 December 2023.

Do not miss this opportunity to ask any questions!